Journo leaders in the UK warn on old regulations for new healthcare AI

The Financial Times of London is calling for caution—along with standardized and modernized regulation—around AI in healthcare.

In a brief editorial published online June 21, the influential newspaper’s editorial board acknowledges several worthwhile innovations AI is bringing to Britain’s healthcare system. However, the team warns, more oversight is needed lest the technology “prove more of a liability than an asset.”

“There are clear advantages to tireless automated assistants and researchers capable of sorting through vast piles of data,” they write. “Yet there is a danger that the new technology falls into a regulatory grey area. The lack of a single bar risks companies applying various standards to products which directly affect the public.”

Read the whole thing:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”